LEAP THERAPEUTICS, INC. — Director's Dealing 2017

Jan 24, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2017-01-20

Reporting Person: CAVANAUGH JAMES H (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2618406	Indirect

Footnotes

F1: Consists of 2,618,406 shares held by HealthCare Ventures VIII, L.P. Christopher K. Mirabelli, James H. Cavanaugh, John W. Littlechild, Harold Werner and Augustine Lawlor (collectively, the "HCVVIII Directors") are the Managing Directors of HealthCare Partners VIII, LLC ("HCPVIII LLC"), which is the General Partner of HealthCare Partners VIII, L.P. ("HCPVIII"), which is the General Partner of HealthCare Ventures VIII, L.P. Each of the HCVVIII Directors, HCPVIII LLC and HCPVIII beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures VIII, L.P. James H. Cavanaugh disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest in these securities.